In another study, Pal et al. designed an MNPs-Abs-based fluorescence spectroscopic platform to analyze ovarian cancer biomarkers [cancer antigen 125 (CA-125), β2-microglobulin (β2-M), and Apolipoprotein A1 (ApoA1)]. The gene discussed is APOA1; the disease is ovarian carcinoma.